Literature DB >> 12114740

HLA-D Antigen Expression and Langerhans' Cell Infiltrates in Thyroid Tumors.

Simon L. Raphael1, Sylvia L. Asa.   

Abstract

Papillary carcinomas (PCs) of thyroid are among the most common but least aggressive human malignancies. The factors explaining the indolence of these tumors are unknown but host-tumor immune interactions may play a role. This study was designed to determine if there is morphologic evidence of these. Frozen tissues collected from 21 PCs, 4 follicular adenomas (FAs), 4 follicular carcinomas (FCs), and 11 nodular hyperplasias (NHs) were stained immunohistochemically for HlLA-D antigens, lymphocyte, and macrophage markers; results were graded numerically. Paraffin-embedded tumors (35 PCs, 10 FAs, and 10 FCs) were stained for 5-100 protein to detect Langerhans' cells (LCs). Diffuse staining for HLA-D antigens and heavy mononuclear infiltrates were found more commonly in PCs compared to follicular neoplasms (FNs) or NHs. No consistent relationship was found between lymphocyte/macrophage infiltrates and expression of HLA-D antigens. The largest number of LCs was in PCs (median 11.8 cells/standard microscopic field [c/smf]), fewer cells were found in FA (3.7 c/smf), and the least in FC (0.05 c/smf). Features of host-tumor interaction including HLA-D expression and infiltrates with lymphocyte macrophages and LC are more strongly expressed in PC than other tumors. This may play a role in explaining their biological behavior.

Entities:  

Year:  1995        PMID: 12114740     DOI: 10.1007/bf02739883

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  36 in total

Review 1.  Papillary neoplasms of the thyroid. Pathologic and prognostic features.

Authors:  V A LiVolsi
Journal:  Am J Clin Pathol       Date:  1992-03       Impact factor: 2.493

2.  Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity.

Authors:  M Bagnasco; D Venuti; F Paolieri; G Torre; S Ferrini; G W Canonica
Journal:  J Clin Endocrinol Metab       Date:  1989-10       Impact factor: 5.958

3.  Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin.

Authors:  P Natali; A Bigotti; R Cavalieri; M R Nicotra; R Tecce; D Manfredi; Y X Chen; L M Nadler; S Ferrone
Journal:  Hum Immunol       Date:  1986-02       Impact factor: 2.850

Review 4.  Analogous functions of macrophages and Langerhans cells in the initiation in the immune response.

Authors:  G Stingl; S I Katz; E M Shevach; A S Rosenthal; I Green
Journal:  J Invest Dermatol       Date:  1978-07       Impact factor: 8.551

5.  Changes in Ia-like antigen expression on malignant human cells.

Authors:  P G Natali; C De Martino; V Quaranta; A Bigotti; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Role of antibody to S100 protein in diagnostic pathology.

Authors:  H J Kahn; A Marks; H Thom; R Baumal
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

7.  T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis.

Authors:  T Furukawa; S Watanabe; T Kodama; Y Sato; Y Shimosato; K Suemasu
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

8.  Lymphocytic infiltration in juvenile thyroid carcinoma.

Authors:  H Kamma; K Fujii; T Ogata
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

9.  Histiocytes in nasopharyngeal carcinoma in relation to prognosis.

Authors:  H Nomori; S Watanabe; T Nakajima; Y Shimosato; T Kameya
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

10.  HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors.

Authors:  N K Goldsmith; S Dikman; B Bermas; T F Davies; S H Roman
Journal:  Clin Immunol Immunopathol       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.